Novo Nordisk announced updates to the Wegovy® savings program, allowing all eligible cash-paying patients access to Wegovy® ...

Novo Nordisk (NVO) announced updates to the Wegovy savings program, allowing all eligible cash-paying patients access to Wegovy injection 0.25 ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients ... This includes 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg dose strengths.

Note: This chart highlights the basics of Wegovy’s dosage in milligrams (mg). You can then read on for more details. Wegovy comes as a liquid solution in a single-dose prefilled injection pen.

Novo Nordisk is cutting the price of its weight-loss drug Wegovy to $499 per month for cash ... Customers who buy a month's supply of 2.5 mg vials will pay $349, and 5 mg vials will cost $499.

According to the company press release, NovoCare Pharmacy is providing Wegovy in 0.25 mg, 0.5 mg. 1 mg, 1.7 mg and 2.4 mg doses. Patients who want to purchase the drug through the program can have ...

Through NovoCare, the company will offer its obesity medicine Wegovy (semaglutide) at 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg doses for uninsured patients or those with commercial insurance but ...

Allurion Technologies' gastric balloon and Novo Nordisk's semaglutide achieved 20.3% weight loss in a trial. Read more here.